연구성과로 돌아가기

2021 연구자 정보 (483 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, Min -Jong
(Kim, MJ)
Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Cell & Matrix Res Inst, Daegu, South Korea

[JCR상위 19.9] Ursolic acid inhibits FceRI-mediated mast cell activation and allergic inflammation SCIE 19.9 IMMUNOLOGY;PHARMACOLOGY & PHARMACY dkhang@gachon.ac.kr;shkim72@knu.ac.kr;
Kim, Young Jo
(Kim, YJ)
Yeungnam Univ Hosp, Dept Internal Med, Div Cardiol, Daegu, South Korea
Yeungnam Univ Med Ctr, Dept Internal Med, Daegu, South Korea
Yeungnam Univ Hosp, Daegu, South Korea


[JCR상위 19.9] Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers Analysis of Data From the KAMIR-NIH Registry
[JCR상위 4.8] Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction
[JCR상위 38.5] Multivessel versus IRA-only PCI in patients with NSTEMI and severe left ventricular systolic dysfunction
SCIE 4.8 CARDIAC & CARDIOVASCULAR SYSTEMS
CARDIAC & CARDIOVASCULAR SYSTEMS;PHARMACOLOGY & PHARMACY
MULTIDISCIPLINARY SCIENCES
hanname@hanmail.net;
sejjoo@jejunu.ac.kr;
mirinesilver@catholic.ac.kr;
Koo, Bon-Kwon
(Koo, BK)
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea J-5374-2012
Koo, Bon-Kwon

[JCR상위 19.9] Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers Analysis of Data From the KAMIR-NIH Registry SCIE 19.9 CARDIAC & CARDIOVASCULAR SYSTEMS hanname@hanmail.net;
Lee, Byung Seok
(Lee, BS)
Chungnam Natl Univ, Dept Gastroenterol & Hepatol, Sch Med, Daejeon, South Korea

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Lee, Do Yup
(Lee, DY)
Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea
Seoul Natl Univ, Res Inst Agr & Life Sci, Ctr Food & Bioconvergence, Dept Agr Biotechnol, Seoul 08826, South Korea


[JCR상위 19.9] Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
[JCR상위 16.5] Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease
SCIE 16.5 GASTROENTEROLOGY & HEPATOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL;ONCOLOGY
bykim@chunlab.com;ktsuk@hallym.ac.kr;
ktsuk@hallym.ac.kr;rome73@snu.ac.kr;
Lee, Jin-Woo
(Lee, JW)
Inha Univ, Dept Internal Med, Sch Med, Incheon, South Korea D-5883-2012
Lee, Shin-Jae

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Lee, Wan Sik
(Lee, WS)
Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju, South Korea
Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea
J-9324-2013
Lee, In

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial
[JCR상위 19.8] Comparison between endoscopic submucosal resection and surgery for the curative resection of undifferentiated-type early gastric cancer within expanded indications: a nationwide multi-center study
SCIE 19.8 GASTROENTEROLOGY & HEPATOLOGY
GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY
umsh@korea.ac.kr;
sgun9139@gmail.com;
Lim, Young Suk
(Lim, YS)
Univ Ulsan, Dept Gastroenterol, Asan Med Ctr, Coll Med, Seoul, South Korea AFQ-5165-2022
Lim, Young-Suk

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Park, Chan Soon
(Park, CS)
제1저자 Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

0000-0003-1717-6662
Park, Chan Soon
[JCR상위 19.9] Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers Analysis of Data From the KAMIR-NIH Registry
[JCR상위 27.6] Response to beta-blockers and natriuretic peptide level in acute heart failure: analysis of data from the Korean acute heart failure registry
SCIE 19.9 CARDIAC & CARDIOVASCULAR SYSTEMS hanname@hanmail.net;
djchoi@snubh.org;
Park, Kyung Woo
(Park, KW)
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea AAX-3046-2020
Park, Kyung Woo

[JCR상위 19.9] Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers Analysis of Data From the KAMIR-NIH Registry SCIE 19.9 CARDIAC & CARDIOVASCULAR SYSTEMS hanname@hanmail.net;
Park, Kyung-Duck
(Park, KD)
제1저자 교신저자 Kyungpook Natl Univ, Sch Med, Dept Dermatol, Daegu, South Korea

[JCR상위 19.9] Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation SCIE 19.9 IMMUNOLOGY;PHARMACOLOGY & PHARMACY gdpk1217@knu.ac.kr;shkim72@knu.ac.kr;
Park, Sung Jae
(Park, SJ)
Inje Univ, Paik Hosp, Dept Internal Med, Busan, South Korea

[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Park, Tae Sik
(Park, TS)
Gachon Univ, Dept Life Sci, Sungnam, South Korea

[JCR상위 19.9] Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY bykim@chunlab.com;ktsuk@hallym.ac.kr;
Sohn, Joo Hyun
(Sohn, JH)
Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
Hanyang Univ, Coll Med, Hanyang Univ Hosp, Dept Internal Med, Seoul, South Korea


[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial
[JCR상위 5.9] IMPACT OF HBEAG ON HEPATOCELLULAR CARCINOMA RISK DURING ORAL ANTIVIRAL TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B
SCIE 5.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
Song, Do Seon
(Song, DS)
제1저자 Catholic Univ Korea, Dept Internal Med, St Vincents Hosp, Seoul, South Korea
0000-0002-8278-4878
Song, Do Seon
[JCR상위 19.9] Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial SCIE 19.9 GASTROENTEROLOGY & HEPATOLOGY umsh@korea.ac.kr;
페이지 이동: